Back to results
US 2021/0198336 A1Published application
Il-2r-beta-gamma binding compounds
AssigneeMedikine, Inc.
InventorsWILLIAM J. DOWER, MICHAEL C. NEEDELS, RONALD W. BARRETT, ALICE V. BAKKER, STEVEN E. CWIRLA
Life of this patent
Estimating the term…
Abstract
IL-2Rβγc binding compounds, and pharmaceutical compositions comprising the IL-2Rβγc binding compounds are disclosed. IL-2Rβγc binding compounds can act as IL-2R agonists and are useful in treating cancer, autoimmune diseases and inflammatory diseases.
Claims20
An IL-2Rβγc binding compound, wherein the IL-2Rβγc binding compound comprises an IL-2Rβγc ligand, wherein the 2Rβγc ligand comprises:
- a ligand linker;
- the IL-2Rβ ligand bound to the ligand linker, wherein the IL-2Rβ ligand comprises an amino acid sequence of any one of SEQ ID NOS:
- 805-903, 911-930, 2575-2655, 2661-2891, 2900-2926, or 2929-2939;
- and
- the IL-2Rγc ligand bound to the ligand linker, wherein the IL-2Rγc ligand comprises an amino acid sequence of any one of SEQ ID NOS:
- 944-1028, 1032-1060, and 1601-1613.
3 more elements
Dependencies are inferred from the claim text.